Format

Send to

Choose Destination
J Stroke Cerebrovasc Dis. 2016 Sep;25(9):e161-2. doi: 10.1016/j.jstrokecerebrovasdis.2016.06.037. Epub 2016 Jul 18.

Recurrent Stroke due to Patent Foramen Ovale Closure Device Thrombus Eight Years after Implantation.

Author information

1
Department of Neurology, Hofstra Northwell School of Medicine, North Shore University Hospital, Manhasset, New York. Electronic address: tkodanka12@northwell.edu.
2
Department of Neurology, Hofstra Northwell School of Medicine, North Shore University Hospital, Manhasset, New York.

Abstract

Patent foramen ovale (PFO) is a common heart defect and is found in about 25% of the general population. Although randomized trials have failed to show the superiority of percutaneous closure of PFO over medical management, the number of patients with closure device placement has grown over the years. Delayed complications from PFO closure are rare. We present a case of cardioembolic stroke secondary to a mobile thrombus on a PFO closure device 8 years after implantation.

KEYWORDS:

CardioSEAL/StarFLEX; Embolism; PFO closure device thrombus; cardiac; cerebrovascular disease; magnetic resonance imaging

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center